Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Eurofins Scientific (ENXTPA:ERF) is in focus after releasing its full year 2025 results, outlining higher earnings, a proposed 20% dividend increase, and completion of a share buyback tranche ...

Figure 1: Recurrent ERF loss-of-function mutations and focal deletions are found in prostate cancer and are mostly exclusive to tumours without TMPRSS2–ERG. Figure 2: ERF is a tumour suppressor, a ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Enerplus Corporation ERF is set to report third-quarter 2022 results on Nov 3, after the closing bell. In the last reported quarter, Enerplus missed the Zacks Consensus Estimate. It outpaced the ...

Due to the increasing oil and gas production in the Bakken region and Marcellus, I expect Enerplus’ total production to increase. However, oil and natural gas prices have decreased significantly and ...

Weather and nat gas prices will likely cause ERF to miss its Q4 guidance. While not expensive, the stock's valuation is in line with its closest peer. ERF should consider divesting its non-operated ...